Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
421.44%Debt to Assets Ratio
VS
Market
Sector
Industry
History
$ 2.54Close
$ 1.18 - $ 11.68 52-Week Range
Ticker Information
Ticker
BTAICompany Name
BIOXCEL THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQBIOXCEL THERAPEUTICS INC - Debt to Assets Ratio Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
BTAI - Debt to Assets Historical data
| Date | Total Assets | Total Debt | Debt to Assets Ratio |
|---|---|---|---|
| 6/30/2025 | $ 25.79M | $ 108.69M | 421.44% |
| 3/31/2025 | $ 38.57M | $ 105.53M | 273.62% |
| 12/31/2024 | $ 38.34M | $ 102.57M | 267.55% |
| 9/30/2024 | $ 48.89M | $ 104.6M | 213.94% |
| 6/30/2024 | $ 65.44M | $ 103.26M | 157.81% |
| 3/31/2024 | $ 82.32M | $ 101.98M | 123.88% |
| 12/31/2023 | $ 73.7M | $ 101.04M | 137.09% |
| 9/30/2023 | $ 100.45M | $ 99.62M | 99.18% |
| 6/30/2023 | $ 140.1M | $ 97.46M | 69.57% |
| 3/31/2023 | $ 180.1M | $ 95.77M | 53.17% |
Key Performance Insights, Last 5 Years
- BIOXCEL THERAPEUTICS INC's latest trailing twelve months (TTM) Debt to Assets stands at 0.61%.
- Over the past 5 years, BIOXCEL THERAPEUTICS INC's average Debt to Assets has been 96.47%.
- The median Debt to Assets for BIOXCEL THERAPEUTICS INC during this period was 49.38%
- BIOXCEL THERAPEUTICS INC reached its highest Debt to Assets over the past 5 years at 421.44%.
- The lowest Debt to Assets recorded by BIOXCEL THERAPEUTICS INC in the same timeframe 0.45%
BIOXCEL THERAPEUTICS INC's Debt to Assets vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Debt to Assets Benchmarks
Similar metrics to Debt to Assets:
- Debt to Equity Ratio - [Calculation] Debt to Equity (D/E) measures the ratio between a company’s [Liabilities] and [Equity]. A high ratio might indicate more risk.
- Cash to Assets Ratio - [Calculation] The Cash to Assets Ratio expresses a company’s cash and cash equivalents [CashnEq] as a percentage of total [Assets].
- Total Assets - [Balance Sheet] An asset represents anything that has current and/or future economic value to a company. This includes Cash [CashnEq], [Investments], [Intangibles], [Receivables] and more.
- Inventory to Assets Ratio - [Calculation] [Inventory] as percentage of total [Assets], serves as an efficiency ratio - the lower the better.
- Gross Profits to Assets - [Calculation] Gross Profits to Assets (GPA) measures how effective a company leverages its assets to generate gross profits. It is calculated as gross profits [GP] divided by [Assets].
Definition of Debt to Assets Ratio
[Calculation] Debt to Assets measures the ratio between a company’s [Liabilities] and [Assets]. A high ratio might indicate more risk.Debt / Assets
(=) Debt to Assets Debt to Assets for BIOXCEL THERAPEUTICS INC is calculated as follows: Debt [ $ 1.47M ] / Assets [ $ 238.75M ]
(=) Debt to Assets [ 0.61% ] BTAI - Debt to Assets Ratio, Last 5 years
0.45%
Minimum
Jun 30, 2021
421.44%
Maximum
Jun 30, 2025
96.47%
Average
49.38%
Median
Debt to Assets Benchmark AnalysisMarket
The chart above depicts the distribution of Debt to Assets for companies in the Total Stock Market. The average Debt to Assets of the companies is 26.33% with a standard deviation of 24.49%.
The following table provides additional summary stats:
Debt to Assets in the Market:
| filtered constituents | 4.37K |
|---|---|
| min | 0% |
| max | 116.6% |
| average | 26.33% |
| median | 21.09% |
| std | 24.49% |